Austin, Texas (PRWEB) October 25, 2011
ProPep Surgical, LLC, a privately-held, Austin-based medical device company, announced today that It has received a Notice of Allowance from the United States Patent and Trademark Office for its System and Method for Laparoscopic Nerve Detection (application 11/745,505). This Notice allowed 20 claims and is the first Notice received on a series of patents the Company has filed or will be filing on their ground breaking ProPep Nerve Monitoring System.
The ProPep Nerve Monitoring System is the first, real-time nerve identification system specifically designed for use during robotic surgery. Fast, accurate and easy to use, the System aids a surgeon in identifying otherwise invisible nerves during minimally invasive robotic pelvic surgery. “Currently, surgeons rely on anatomic landmarks to identify these nerves during surgery. Unfortunately, these landmarks are not always reliable,” according to Dr. Randy Fagin, Chief Medical Officer. “By helping the surgeon identify these nerves in real-time during the surgical procedure, the ProPep Nerve Monitoring System allows the surgeon to make a more informed decision about which tissue to selectively preserve or remove during an operation and as a result, potentially reduce the incidence of nerve damage related side effects such as incontinence and sexual dysfunction following robotic prostatectomy surgery.”
“We are very excited to be granted these 20 claims on our first generation Nerve Monitoring System,” stated Jim Schneider, Chief Operating Officer. “It is a great first step toward building a world class intellectual property estate around our unique nerve monitoring technology. We look forward to continued success in the development of our technology and patent estate, and to ultimately providing robotic surgeons the same nerve monitoring capabilities that have been Standard of Care in multiple open surgical procedures for decades.”
About ProPep Surgical, LLC
Established in 2010, ProPep Surgical is a privately-held, Austin-based medical device company developing a system of products (ProPep Nerve Monitoring System) to aid robotic surgeons in identifying otherwise invisible nerves during minimally invasive robotic surgery. Real time identification of these nerves will allow the surgeons to make a more informed decision about which tissue to selectively preserve or remove during an operation and as a result, potentially reduce the common side effects typically attributed to inadvertent nerve damage during robotic surgery.
# # #